top of page
Profile
Join date: Jan 4, 2020
Posts (39)
Jun 10, 2025 ∙ 1 min
Sage Group Advises Fabre-Kramer Pharma on Partnering Deal with Aytu Biopharma for EXXUA(TM), a Newly Approved and Innovative Treatment for Major Depressive Disorder
Aytu BioPharma Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics,...
13
0
Mar 13, 2025 ∙ 2 min
Sage New Client: Notogen's Groundbreaking Regenerative Therapy for Degenerative Disc Disease
Sage Group's new client, Notogen, is a US registered company focused on a regenerative therapeutic, designated NTG-101, for treating...
30
0
Mar 11, 2025 ∙ 4 min
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PETACH TIKVA, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage...
17
0
bil19
Admin
More actions
bottom of page